Fig. 2From: High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroidsChange from baseline in average pre-dose morning PEF (L/min) [95% CI] – ITT populationBack to article page